Rapidly Progressive Behavioral Syndrome Without Spastic Paraplegia in a Patient With SPAST p.Pro26Thr Variant

DOI QR Code

Faheem Arshad (Department of Neurology, National Institute of Mental Health and Neurosciences (NIMHANS)) ;
Suvarna Alladi (Department of Neurology, National Institute of Mental Health and Neurosciences (NIMHANS)) ;
Karthik Kulanthaivelu (Department of Neuroimaging and Interventional Radiology, National Institute of Mental Health and Neurosciences (NIMHANS))

Konno T, Yoshida K, Mizuno T, Kawarai T, Tada M, Nozaki H, et al. Clinical and genetic characterization of adult-onset leukoencephalopathy with axonal spheroids and pigmented glia associated with CSF1R mutation. Eur J Neurol 2017;24:37-45.
Lynch DS, Zhang WJ, Lakshmanan R, Kinsella JA, Uzun GA, Karbay M, et al. Analysis of mutations in AARS2 in a series of CSF1R-negative patients with adult-onset leukoencephalopathy with axonal spheroids and pigmented glia. JAMA Neurol 2016;73:1433-1439.
Chamard L, Ferreira S, Pijoff A, Silvestre M, Berger E, Magnin E. Cognitive impairment involving social cognition in SPG4 hereditary spastic paraplegia. Behav Neurol 2016;2016:6423461.
Murphy S, Gorman G, Beetz C, Byrne P, Dytko M, McMonagle P, et al. Dementia in SPG4 hereditary spastic paraplegia: clinical, genetic, and neuropathologic evidence. Neurology 2009;73:378-384.
Schieving JH, de Bot ST, van de Pol LA, Wolf NI, Brilstra EH, Frints SG, et al. De novo SPAST mutations may cause a complex SPG4 phenotype. Brain 2019;142:e31.
Schulze TG, McMahon FJ. Defining the phenotype in human genetic studies: forward genetics and reverse phenotyping. Hum Hered 2004;58:131-138.